<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05064501</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-COV-2020-129</org_study_id>
    <nct_id>NCT05064501</nct_id>
  </id_info>
  <brief_title>Impact of COVID19 on Asthma</brief_title>
  <acronym>IMCAS proyect</acronym>
  <official_title>Impact of COVID19 on Lung Function and Control of Asthma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sociedad Española de Neumología y Cirugía Torácica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The COVID19 pandemic is having an immeasurable impact on the economy and on morbidity and&#xD;
      mortality. Knowledge and scientific evidence about this disease is advancing rapidly, but it&#xD;
      is not yet known whether asthmatic patients suffering from COVID19 have an exacerbation of&#xD;
      asthma, or whether this viral infection has an impact on control and lung function in the&#xD;
      short to medium term.&#xD;
&#xD;
      The aim of this study is to define the changes that occur in these two parameters in&#xD;
      asthmatic patients suffering from COVID19. To this end, asthmatic patients who have suffered&#xD;
      a SARS-CoV-2 infection and who have required an emergency consultation or hospitalisation&#xD;
      will be collected in a pneumology consultation and matched by age, sex and severity of asthma&#xD;
      with a group that has not suffered the same. Both will be followed for one year, and lung&#xD;
      function will be tested at six months and exacerbations and changes in ACT during the&#xD;
      following year.&#xD;
&#xD;
      These data are intended to improve the available knowledge on the impact of IDVC19 on asthma&#xD;
      patients with a view to making appropriate recommendations, prevention and treatment&#xD;
      adjustments in line with the results obtained.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Asthma control</measure>
    <time_frame>6 months</time_frame>
    <description>Change in score of ACT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma function</measure>
    <time_frame>6 months</time_frame>
    <description>Change in FEV1</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Asthma</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Asthma and COVID19 infection</arm_group_label>
    <description>Asthma and COVID19 infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asthma without COVID19 infection</arm_group_label>
    <description>Asthma and COVID19 infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>spirometry</intervention_name>
    <description>Lung function test: pre and post bronchodilator spirometry</description>
    <arm_group_label>Asthma and COVID19 infection</arm_group_label>
    <arm_group_label>Asthma without COVID19 infection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Asthma control test</intervention_name>
    <description>Asthma control test</description>
    <arm_group_label>Asthma and COVID19 infection</arm_group_label>
    <arm_group_label>Asthma without COVID19 infection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients between the ages of 12 and 80 diagnosed with asthma according to current&#xD;
        guidelines (GEMA/GINA), of any level of severity, will be recruited and followed up in&#xD;
        Pneumology consultations at participating hospitals. The study cohort would be patients&#xD;
        with these criteria who have needed to consult the Emergency Department or be admitted for&#xD;
        COVID19 (suggestive symptomatology + CRP and/or positive serology) in the six months prior&#xD;
        to the visit. The control group would be a cohort of asthmatic patients matched by age,&#xD;
        severity and sex, who have not suffered COVID19 or compatible symptoms.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  12 -80 years&#xD;
&#xD;
          -  Asthma diagnosis according to guidelines&#xD;
&#xD;
          -  Follow up on asthma clinics in one of the participant hospitals&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other severe respiratory condition independent of asthma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Elena Curto, MD</last_name>
    <phone>699877357</phone>
    <email>ecurto@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Curto, MD</last_name>
      <phone>699877357</phone>
      <email>ecurto@santpau.cat</email>
    </contact>
    <contact_backup>
      <last_name>Elena Curto, MD</last_name>
      <phone>932919000</phone>
      <phone_ext>5971</phone_ext>
      <email>ecurto@santpau.cat</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 30, 2021</study_first_submitted>
  <study_first_submitted_qc>September 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2021</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</investigator_affiliation>
    <investigator_full_name>Astrid Crespo</investigator_full_name>
    <investigator_title>Dr. Astrid Crespo</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>asthma control</keyword>
  <keyword>COVID19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

